Navigation Links
Eurofins MWG Operon and Integrated Genomics cooperate to provide complete genome projects

Ebersberg, Germany and Mount Prospect, IL, USA, 05. October, 2011 Eurofins MWG Operon and Integrated Genomics have announced a co-operation agreement to combine their expertise in sequencing and analysis services for microbial, fungal, and algal organisms. Integrated Genomics, based in Mount Prospect, Illinois, is the leading commercial provider of microbial bioinformatics tools and services based on the ERGO(tm) genome sequence analysis platform. Eurofins MWG Operon, based in Ebersberg, Germany, and a member of the Eurofins Group, is one of the leading global providers of DNA sequencing services, DNA synthesis products and bioinformatics services for academic and industrial research.

The goal of the cooperation is to provide customers "one-stop-shopping" for complete genome projects that delivers analysis results from the raw extracted DNA. Both companies together serve a worldwide market for their products and services.

"We take specific care to build up a technical and operational pipeline which is suitable to meet our quality standards and the high service level we want to provide to our customers", says Bruno Poddevin, Eurofins Senior Vice President, Genomic Services. "The specific know-how and bioinformatics capabilities of Integrated Genomics are an excellent fit to our portfolio for prokaryotic, yeast and fungal genome sequencing services."

"As a leader in the next generation sequencing technology, Eurofins has long been our preferred sequencing partner. With this increased integration we are now able to provide complete genome sequencing and analysis projects for our customers", says John W. Elling, CEO of Integrated Genomics.


Contact: Georg Gradl
Eurofins MWG Operon

Page: 1

Related biology news :

1. Verizon Business to Provide Global IP for Eurofins Scientific
2. Eurofins MWG Operon and Genomatix launch strategic alliance
3. Eurofins MWG Operon and Genomatix developed most complete human exome array
4. Eurofins MWG Operon signs contract to supply oligonucleotides to Research Councils
5. Eurofins MWG Operon adds Roche GS Junior to its sequencer fleet
6. Eurofins MWG Operon signs contract to supply DNA sequencing services to Research Councils
7. Eurofins MWG Operon offers advanced de novo genome sequencing
8. Eurofins MWG Operon launches sequencing service on PacBio RS system
9. Eurofins MWG Operon and Integrated Genomics cooperate to provide complete genomics projects
10. Integrated curriculum enhances academics
11. Climate change aims need to be better integrated
Post Your Comments:
(Date:6/2/2016)... 2, 2016 Perimeter Surveillance & ... Systems, Physical Infrastructure, Support & Other Service  ... offers comprehensive analysis of the global Border ... generate revenues of $17.98 billion in 2016. ... a leader in software and hardware technologies for advanced ...
(Date:5/12/2016)... , May 12, 2016 ... just published the overview results from the Q1 wave ... the recent wave was consumers, receptivity to a program ... data with a health insurance company. "We ... to share," says Michael LaColla , CEO of ...
(Date:4/26/2016)... LONDON , April 26, 2016 /PRNewswire/ ... Systems, a product subsidiary of Infosys (NYSE: ... partnership to integrate the Onegini mobile security platform ... ) The integration ... security to access and transact across channels. Using ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... While the ... such as the Cary 5000 and the 6000i models are higher end machines that ... the height of the spectrophotometer’s light beam from the bottom of the cuvette holder. ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge (BDC), ... new ways to harness living systems and biotechnology, announced ... (MoMA) in New York City . ... participating students, showcased projects at MoMA,s Celeste Bartos Theater ... Antonelli , MoMA,s senior curator of architecture and design, ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology: